ReviewFrontiers in pharmacology2026

Toward the rational design of oncogenic TASK-3 channel inhibitor peptides and nanoconjugate complexes.

Leandro Zúñiga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.